Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma

• Autori principali: Faiena I (Autore), Cummings AL (Autore), Crosetti AM (Autore), Pantuck AJ (Autore), Chamie K (Autore), Drakaki A (Autore)
• Natura: Libro
• Pubblicazione: Dove Medical Press, 2018-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Izak Faiena,1,2 Amy L Cummings,3 Anna M Crosetti,3 Allan J Pantuck,1,2 Karim Chamie,1,2 Alexandra Drakaki1–3 1Department of Urology, 2Institute of Urologic Oncology, 3Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at University of California, L...